Fujii N - Search Results

1

Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function.

Imaizumi T, Fujii N, Hamano T, Yang W, Taguri M, Kansal M, Mehta R, Shafi T, Taliercio J, Go A, Rao P, Hamm LL, Deo R, Maruyama S, Fukagawa M, Feldman HI; CRIC Study Investigators. Imaizumi T, et al. Among authors: fujii n. Kidney Int. 2023 May;103(5):949-961. doi: 10.1016/j.kint.2023.01.008. Epub 2023 Feb 2. Kidney Int. 2023. PMID: 36738890 Free PMC article.

2

Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.

Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M. Hamano T, et al. Among authors: fujii n. Bone. 2005 May;36(5):909-16. doi: 10.1016/j.bone.2005.02.008. Epub 2005 Mar 24. Bone. 2005. PMID: 15794928

3

Different routes bridging calcium in Japanese hemodialysis patients.

Hamano T, Fujii N, Ito T, Imai E. Hamano T, et al. Among authors: fujii n. Ther Apher Dial. 2005 Feb;9(1):32-8. doi: 10.1111/j.1774-9987.2005.00211.x. Ther Apher Dial. 2005. PMID: 15828903

4

[Risedronate: a possible treatment for extraosseous calcification].

Fujii N, Hamano T, Isaka Y, Ito T, Imai E. Fujii N, et al. Clin Calcium. 2005 Sep;15 Suppl 1:75-8; discussion 78-9. Clin Calcium. 2005. PMID: 16272635 Japanese.

5

[Low dose estrogen replacement therapy (ERT) for postmenopausal hemodialysis (HD) patients].

Hamano T, Fujii N, Ito T, Imai E, Mikami S, Katayama M, Obi Y. Hamano T, et al. Among authors: fujii n. Clin Calcium. 2005 Sep;15 Suppl 1:161-6; discussion 166. Clin Calcium. 2005. PMID: 16279020 Clinical Trial. Japanese.

6

Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.

Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Okada N, Imai E, Horio M, Ito T. Hamano T, et al. Among authors: fujii n. Bone. 2006 Nov;39(5):1067-1072. doi: 10.1016/j.bone.2006.04.022. Epub 2006 Jun 16. Bone. 2006. PMID: 16781904

7

Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).

Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Fujii N, et al. Nephrol Dial Transplant. 2007 Jun;22(6):1601-7. doi: 10.1093/ndt/gfl567. Epub 2006 Nov 23. Nephrol Dial Transplant. 2007. PMID: 17124283 Clinical Trial.

8

Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.

Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M. Mikami S, et al. Among authors: fujii n. Hypertens Res. 2008 Jun;31(6):1163-70. doi: 10.1291/hypres.31.1163. Hypertens Res. 2008. PMID: 18716364

9

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H. Tomida K, et al. Among authors: fujii n. Bone. 2009 Apr;44(4):678-83. doi: 10.1016/j.bone.2008.11.016. Epub 2008 Dec 9. Bone. 2009. PMID: 19111635

10

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure.

Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y. Matsui I, et al. Among authors: fujii n. Kidney Int. 2009 May;75(9):915-28. doi: 10.1038/ki.2008.700. Epub 2009 Feb 4. Kidney Int. 2009. PMID: 19190677 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,061 results

Search Page